Filling the need for trusted information on national health issues…

J&J Announces Collaboration With Stop TB Partnership To Improve Access To TB Drug

Media sources report on efforts by Johnson & Johnson to improve access to Sirturo, its medication for drug-resistant tuberculosis (TB).

Bloomberg News: J&J Eases Access for Tuberculosis Drug in Poor Nations
“Johnson & Johnson is taking steps to ensure Sirturo, its medicine for people with drug-resistant tuberculosis, is available and properly administered in 130 developing countries across the globe…” (Cortez, 4/29).

Johnson & Johnson: Johnson & Johnson Announces New Collaboration with Stop TB Partnership’s Global Drug Facility to Enhance Access to Anti-TB Compound
“Johnson & Johnson [Tuesday] announced that its affiliate Janssen Pharmaceutica NV (Janssen) has entered into a novel collaboration with the Stichting International Dispensary Association (IDA), a procurement agent for the Stop TB Partnership’s Global Drug Facility (GDF), to facilitate access to the company’s anti-tuberculosis medicine. This public-private partnership was established by the newly formed Janssen Global Public Health and is the latest in the company’s overall efforts to improve public health…” (4/29).

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.